Certain medications should not be used together due to safety concerns. Some drugs can alter blood concentrations of other medications you are taking,···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 109
Grapefruit and grapefruit products may interact with pemigatinib and increase the risk of adverse side effects. Therefore, avoid consuming grapefruit ···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 110
Seek immediate emergency medical help or call the Poison Help hotline.【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 107
Take your dose as soon as you remember. However, if it has been more than 4 hours since your scheduled dose, skip the missed one. Do not take a double···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 104
Pemigatinib demonstrates proven therapeutic activity in patients with previously treated locally advanced/metastatic cholangiocarcinoma and FGFR2 fusi···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 105
While pemigatinib exerts its therapeutic effect, it may cause different types and degrees of side effects due to individual differences in physical co···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 108
Properly understanding the timing of pemitinib administration, dosage adjustment principles, and interactions with food is crucial for improving treat···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 109
FDA Approves Pemigatinib as First-to-Treatment Targeted Therapy for Adult Patients with Previously Treated, Unresectable Locally Advanced or Metastati···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 107
August 26, 2022, Wilmington, Delaware, BUSINESS WIRE.Incyte announced that the U.S. Food and Drug Administration (FDA) has approved pemigatinib® (pemi···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 108
Pemigatinib is developed by Incyte Corporation, USA. In April 2020, the U.S. Food and Drug Administration (FDA) approved pemigatinib for the treatment···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 112
Pemigatinib has proven therapeutic activity in patients with previously treated locally advanced/metastatic cholangiocarcinoma with FGFR2 fusions/rear···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 119
Properly understanding the timing of pemigatinib administration, adjusting the appropriate dosage, and its interactions with food are crucial for impr···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 109
While pemigatinib exerts its therapeutic effect, it may also cause different types and degrees of adverse reactions due to individual differences in p···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 115
The price of Pemigatinib is subject to fluctuations due to factors such as drug specifications, region, medical insurance policies, and purchasing cha···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 97
Pemigatinib is a targeted therapy drug for specific cholangiocarcinoma patients. Its price is affected by factors such as dosage, region, and medical ···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 101
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos



